BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31576147)

  • 21. HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer.
    Jiang J; Wang S; Wang Z; Cai J; Han L; Xie L; Han Q; Wang W; Zhang Y; He X; Yang C
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):295-305. PubMed ID: 32743678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma.
    Chen H; Liu J; Wang H; Cheng Q; Zhou C; Chen X; Ye F
    J Cancer; 2019; 10(6):1580-1592. PubMed ID: 31031868
    [No Abstract]   [Full Text] [Related]  

  • 23. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
    Yao N; Yu L; Zhu B; Gan HY; Guo BQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8127-8134. PubMed ID: 30556850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of CXCL1 gene expression on the biological function of epithelial ovarian carcinoma cells in vitro].
    Zhang W; Huang N; Wang Q; Yang ZJ; Li L
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):109-13. PubMed ID: 23714664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SMAD3 inducing the transcription of  STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel.
    Shi Y; Zhang J; Liu M; Huang Y; Yin L
    J Cell Biochem; 2019 Jun; 120(6):10796-10811. PubMed ID: 30701575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.
    Liu H; Shi H; Fan Q; Sun X
    Tumour Biol; 2016 Aug; 37(8):10161-75. PubMed ID: 26831658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo.
    Huang J; Ke P; Guo L; Wang W; Tan H; Liang Y; Yao S
    Int J Gynecol Cancer; 2014 May; 24(4):635-42. PubMed ID: 24758900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on the Relationship Between
    Yue C; Li RH; Chen C; Liu H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):337-341. PubMed ID: 30014630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
    Dong YZ; Meng XM; Li GS
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells.
    Guo J; Chen L; Luo N; Yang W; Qu X; Cheng Z
    Oncol Rep; 2015 Jun; 33(6):3124-30. PubMed ID: 25872785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
    Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A
    Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target.
    Wen X; Lu R; Xie S; Zheng H; Wang H; Wang Y; Sun J; Gao X; Guo L
    Cancer Biomark; 2016 Sep; 17(3):313-322. PubMed ID: 27802207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LINC01094/miR-577 axis regulates the progression of ovarian cancer.
    Xu J; Zhang P; Sun H; Liu Y
    J Ovarian Res; 2020 Oct; 13(1):122. PubMed ID: 33069244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.
    Sang XB; Sun KX; Wang LL; Chen S; Wu DD; Zong ZH; Zhao Y
    Oncol Rep; 2016 Dec; 36(6):3267-3274. PubMed ID: 27748937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chikusetsusaponin IVa methyl ester induces G1 cell cycle arrest, triggers apoptosis and inhibits migration and invasion in ovarian cancer cells.
    Chen X; Wu QS; Meng FC; Tang ZH; Chen X; Lin LG; Chen P; Qiang WA; Wang YT; Zhang QW; Lu JJ
    Phytomedicine; 2016 Dec; 23(13):1555-1565. PubMed ID: 27823619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer].
    Tang XH; Lu MS; Deng S; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2017 Feb; 52(2):110-115. PubMed ID: 28253574
    [No Abstract]   [Full Text] [Related]  

  • 38. Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer.
    Zhu J; Luo JE; Chen Y; Wu Q
    J Ovarian Res; 2021 Oct; 14(1):136. PubMed ID: 34649611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.
    Xing Z; Zhang M; Wang X; Liu J; Liu G; Feng K; Wang X
    J Mol Histol; 2021 Aug; 52(4):809-821. PubMed ID: 34009515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells.
    Zhang M; Liu S; Fu C; Wang X; Zhang M; Liu G; Dai C; Gong Z; Xu H; Fu Z; Xu P; Xu J; Jia X
    Cancer Biother Radiopharm; 2019 Jun; 34(5):316-324. PubMed ID: 30892073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.